The question behind is it worth it
Nobody types this into a search bar out of curiosity. It gets asked when symptoms have been going on long enough to matter and the decision has come down to whether the trade is a fair one.
Three things sit in that trade. How much the symptoms are costing you, what the HRT risks and benefits actually are for someone in your position, and what the monthly bill looks like. Most articles cover one of the three and leave the other two vague.
What the symptoms are already costing
This is the side that rarely gets quantified, and it should be. Hot flashes last a median of about seven years, and for roughly a third of women considerably longer than that.
Broken sleep is where most of the damage compounds. Waking three times a night for months produces fatigue, low mood, irritability and poor concentration in anyone, and those get counted as separate problems when they are usually one.
- Seven years is the median duration of hot flashes, not seven months
- Vaginal dryness is the exception that worsens rather than settling
- Bone loss runs fastest in the five years after your last period, silently
The risk numbers, in context
The 2002 Women's Health Initiative headline still drives most of the fear, and the detail that got lost was the population studied: average age 63, most more than a decade past menopause, on oral conjugated estrogen with a synthetic progestin.
Re-analysis by age tells a different story for women starting near menopause. Before 60, or within ten years of your last period, the balance of benefit to risk looks substantially more favorable.
What actually goes up
Combined estrogen and progestogen therapy carries a small increase in breast cancer risk that grows with duration of use. Oral estrogen raises clot risk through its effect on the liver; estrogen absorbed through the skin has not shown that increase.
What it costs each month
Three separate bills: the consultation, any bloodwork, and the prescription. Only the first comes from the clinic, and the prescription is where the range is widest.
- Generic estradiol tablets: often under $10 for a 90-day supply
- Generic patches: under $40 a month insured, $250 or more without
- Vaginal creams: $25 to $100 a month
- Compounded pellets: around $1,500 a year, covered by nobody
Asking for the generic by name is the single biggest lever on that bill, and it usually costs you nothing clinically.
Those figures are indicative only and move with your plan, your pharmacy and the year. The full breakdown sits in hormone therapy cost, and what a plan will and will not pay for is covered in insurance and coverage.
When the answer is no
For women with current or past hormone-sensitive breast cancer, unexplained vaginal bleeding, a clot history or active liver disease, systemic hormone therapy is generally not the right answer, and a service that prescribes anyway is not assessing anyone.
That is not the end of the conversation. Fezolinetant is one of the non-hormonal options that treats hot flashes without estrogen, cognitive behavioral therapy has real evidence, and low-dose vaginal estrogen is frequently appropriate even where systemic therapy is not.
What the first three months feel like
The decision is easier when you know what you are agreeing to. Very little happens in the first two weeks, which catches people out and is the most common reason women stop before the treatment has had a chance to work.
Sleep usually shifts first, often within two weeks, and mostly because the night sweats waking you have eased. Hot flashes follow over four to twelve weeks. Mood and concentration tend to improve alongside sleep rather than independently of it. Vaginal symptoms treated locally take eight to twelve weeks, because the tissue has to rebuild rather than simply respond.
The review at three months is where the dose gets adjusted, and it is normal to need one adjustment. What to expect sets out the timeline week by week, and dosing and adjusting explains why only one thing changes at a time.
What happens if you stop
This is the part that belongs in the decision and usually is not. Hormone therapy treats symptoms while you take it. It does not cure menopause, and for most women the symptoms return when it stops, sometimes within weeks.
That is not an argument against starting. It is an argument for going in with the right expectation: this is treatment for a phase that lasts years, not a course you finish. Tapering over three to six months is gentler than stopping abruptly, and restarting after a failed attempt to stop is a reasonable clinical decision rather than a failure of willpower.
There is no fixed stopping age. The decision gets reviewed annually against your symptoms and your risk picture as it stands then. Stopping HRT covers how that is usually done, and monitoring and follow-up covers what the annual review looks at.
Two things are worth separating here. Coming off because your symptoms have genuinely settled is a different decision from coming off because you were told five years was the limit. The first is led by how you feel. The second is a rule of thumb that the evidence has already moved past, and it is worth asking which one you are being offered.
How to actually decide
- Write down the three symptoms that bother you most and how much they interfere
- Work out roughly when your last period was, because it sets the treatment window
- Check your plan formulary for estradiol patches and tablets
- Book an assessment and ask what the risk looks like for your specific history
If after all four the answer is still unclear, that is a reasonable place to be, and a trial with a three-month review is a legitimate way to find out rather than a commitment.